Q4 2026 PetVivo Holdings Inc Earnings Call Transcript
Key Points
- PetVivo Holdings Inc (PETV) reported a 1% increase in revenues to $1.14 million for the fiscal year 2026, indicating growth despite challenges.
- The company has formed strategic alliances, including a 10-year white label licensing agreement with Digital Landia for their AgenticPet technology, enhancing their AI capabilities.
- PetVivo AI, a new AI-powered SaaS platform for veterinarians, has shown a significant reduction in customer acquisition costs, from $80-$400 to less than $43 per customer.
- The acquisition of PiezoBioMembrane is expected to accelerate the development of new biomaterials and therapeutic technologies, enhancing PetVivo's product pipeline.
- Health Canada recognized Spryng with OsteoCushion Technology as a veterinary medical device, opening new international market opportunities in Canada.
- Gross profit decreased to 66.1% of revenues from 87.8% the previous year, primarily due to low margins associated with the PrecisePRP product line.
- Operating expenses increased by 8% to $9.8 million, driven by a loss on impairment for the PrecisePRP product line and increased sales and marketing expenses.
- The company reported a net loss of $10.5 million for fiscal year 2026, up from a net loss of $8.4 million the previous year.
- Market acceptance of the PrecisePRP products was lower than expected, leading to a $1 million impairment expense and renegotiations with VetStem.
- Despite the increase in revenues, the company faced challenges with the sales mix, as customers opted to use PrecisePRP alone instead of in conjunction with Spryng.
Good afternoon, everyone. Thank you for joining us today to discuss our results for our fiscal year 2026 ended March 31, 2026.
Before we begin, I'd like to direct your attention to the forward-looking statements slide displayed on your screen.
Throughout today's call, we may discuss the company's future plans, expectations, objectives, anticipated results and other forward-looking statements. Please take a moment to review the information on this slide.
I will also provide the company's complete Safe Harbor statement at the conclusion of today's call.
Hosting the call today is our Chief Executive Officer, John Lai; and our Chief Financial Officer, Garry Lowenthal; as well as myself, John Dolan, PetVivo's Chief Business Development Officer and General Counsel. Following our remarks, we'll open the call to your questions.
Then before we conclude today's call, I will provide some important cautions regarding the forward-looking statements made
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
